Gerard Griffioen
Director Técnico/Científico/I+D en reMYND NV .
Cargos activos de Gerard Griffioen
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
reMYND NV
 reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Director Técnico/Científico/I+D | - | - |
Historial de carrera de Gerard Griffioen
Antiguos cargos conocidos de Gerard Griffioen.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| Katholieke Universiteit Leuven | Corporate Officer/Principal | - | - |
| University of Vienna | Corporate Officer/Principal | - | - |
Formación de Gerard Griffioen.
| Vrije Universiteit Amsterdam | Doctorate Degree |
Estadísticas
Internacional
| Bélgica | 3 |
| Reino Unido | 2 |
| Austria | 2 |
Operativa
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectorial
| Consumer Services | 4 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Commercial Services |
- Bolsa de valores
- Insiders
- Gerard Griffioen
- Experiencia
